News
MRK
99.18
+0.93%
0.91
Merck upgraded to Outperform from Market Perform at BMO Capital
TipRanks · 1h ago
Merck: Undervalued Buy with Robust Pipeline and Diversified Post‑Keytruda Revenue Strategy
TipRanks · 2h ago
SCHD: This ETF Stinks
Seeking Alpha · 11h ago
Merck cholesterol, cancer therapies to receive national priority vouchers - report
Seeking Alpha · 14h ago
FDA aims to fast track two Merck drugs with high sales potential, Reuters says
TipRanks · 14h ago
'U.S. FDA Moving To Fast-Track Reviews Of Two Merck Drugs Under Commissioner National Priority Voucher Pilot Program; Merck's Cholesterol Pill Enlicitide And Cancer Therapy Sac-TMT Tapped For Program; FDA Expects Respective April And October/ November Submission Dates For Enlicitide And Sac-TMT, Internal Documents Say' - Reuters Exclusive
Benzinga · 14h ago
More pharmas expected to sign drug pricing deals with Trump on Friday - report
Seeking Alpha · 17h ago
Merck's Keytruda-Padcev Combo Boosts Survival In Pivotal Bladder Cancer Trial
Benzinga · 17h ago
Pfizer, Merck Are Boring Again — And That's Exactly Why 2026 Investors Are Circling Back
Benzinga · 20h ago
The Ultimate High-Yield Drug Stock to Buy With $1,000 Right Now
The Motley Fool · 21h ago
Merck, Pfizer, Astellas Drug Combo Succeeds in 2nd Phase 3 Bladder Cancer Study
Dow Jones · 22h ago
Pfizer, Astellas post late-stage trial win for Padcev in bladder cancer with Merck’s Keytruda
Seeking Alpha · 23h ago
Merck reports ‘positive’ results from Phase 3 KEYNOTE-B15 trial
TipRanks · 23h ago
CDC signs off on change in newborn hepatitis b vaccine schedule
Seeking Alpha · 1d ago
Should You Buy the 5 Highest-Paying Dividend Stocks in the Dow Jones Before 2026?
The Motley Fool · 1d ago
Dow Movers: MRK, DIS
NASDAQ · 1d ago
Merck, IBM share losses lead Dow's nearly 250-point drop
MarketWatch · 1d ago
Eli Lilly or Merck: Where Should Investors Put Their Money?
NASDAQ · 1d ago
Adagene, Palvella gain after FDA Fast Track Designations
Seeking Alpha · 1d ago
Immutep announces progress in global TACTI-004 Phase III, enrollment continues
TipRanks · 1d ago
More
Webull provides a variety of real-time MRK stock news. You can receive the latest news about Merck & Co through multiple platforms. This information may help you make smarter investment decisions.
About MRK
Merck & Co., Inc. is a global health care company that delivers health solutions through its prescription medicines, including biologic therapies, vaccines and animal health products. Its Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Company sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. It sells these human health vaccines primarily to physicians, wholesalers, distributors and government entities. Its Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all livestock and companion animal species. Its products include KEYTRUDA (pembrolizumab) injection, for intravenous use; WELIREG (belzutifan) tablets, for oral use; Ohtuvayre (ensifentrine) and others.